|
× |
 |
Effectiveness of Aripiprazole, Olanzapine, Quetiapine, and Risperidone Augmentation Treatment for Major Depressive Disorder: A Nationwide Population-Based Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risk Factors for Violent Crime in Schizophrenia: A National Cohort Study of 13,806 Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Neural Correlates of the Affect Regulation Model in Schizophrenia Patients With Substance Use History: A Functional Magnetic Resonance Imaging Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up PDF |
$40.00 |
|
$40.00 |
|
× |
|
Association of Pregnancy-Related Anxiety With Perceived Social Support: An Observational Study Among Third-Trimester Antenatal Women PDF |
$40.00 |
|
$40.00 |
|
× |
|
Pharmacologic Treatment of Postpartum Women With New-Onset Major Depressive Disorder: A Randomized Controlled Trial With Paroxetine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychopharmacologic Treatment Response of HIV-Infected Patients to Antipsychotic Medications PDF |
$40.00 |
|
$40.00 |
|
× |
|
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses PDF |
$40.00 |
|
$40.00 |
|
× |
|
Neuropsychiatric and Behavioral Profiles of 2 Adults With Williams Syndrome: Response to Antidepressant Intake PDF |
$40.00 |
|
$40.00 |
|
× |
|
Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression? PDF |
$40.00 |
|
$40.00 |
|
|
